Literature DB >> 11853957

Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery.

Julie Gehl1, Torben Skovsgaard, Lluis M Mir.   

Abstract

In vivo electroporation (EP) is gaining momentum for drug and gene delivery. In particular, DNA transfer by EP to muscle tissue can lead to highly efficient long-term gene expression. We characterized a vascular effect of in vivo EP and its consequences for drug and gene delivery. Pulses of 10-20,000 micros and 0.1-1.6 kV/cm were applied over hind- and forelimb of mice and perfusion was examined by dye injection. The role of a sympathetically mediated vasoconstrictory reflex was investigated by pretreatment with reserpine. Expression of a transferred gene (luciferase), permeabilization (determined using (51)Cr-EDTA), membrane resealing and effects on perfusion were compared to assess the significance of the vascular effects. Above the permeabilization threshold, a sympathetically mediated Raynaud-like phenomenon with perfusion delays of 1-2 min was observed. Resolution of this phase followed kinetics of membrane resealing. Above a second threshold, irreversible permeabilization led to long perfusion delays. These vascular reactions (1) affect kinetics of drug delivery, (2) predict efficient DNA transfer, which is optimal during short perfusion delays, and (3) might explain electrocardiographic ST segment depressions after defibrillation as being caused by vascular effects of EP of cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11853957     DOI: 10.1016/s0304-4165(01)00233-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  Electroporation of the vasculature and the lung.

Authors:  David A Dean
Journal:  DNA Cell Biol       Date:  2003-12       Impact factor: 3.311

Review 2.  Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals.

Authors:  David A Dean
Journal:  Am J Physiol Cell Physiol       Date:  2005-08       Impact factor: 4.249

3.  Cellular electroporation induces dedifferentiation in intact newt limbs.

Authors:  Donald L Atkinson; Tamara J Stevenson; Eon Joo Park; Matthew D Riedy; Brett Milash; Shannon J Odelberg
Journal:  Dev Biol       Date:  2006-07-29       Impact factor: 3.582

Review 4.  Nucleic acids electrotransfer-based gene therapy (electrogenetherapy): past, current, and future.

Authors:  L M Mir
Journal:  Mol Biotechnol       Date:  2009-06-27       Impact factor: 2.695

Review 5.  Electrochemotherapy for treatment of skin and soft tissue tumours. Update and definition of its role in multimodal therapy.

Authors:  Vicente Muñoz Madero; Gloria Ortega Pérez
Journal:  Clin Transl Oncol       Date:  2011-01       Impact factor: 3.405

6.  Effect of Cooling On Cell Volume and Viability After Nanoelectroporation.

Authors:  Claudia Muratori; Andrei G Pakhomov; Olga N Pakhomova
Journal:  J Membr Biol       Date:  2017-02-27       Impact factor: 1.843

Review 7.  Gene electrotransfer: from biophysical mechanisms to in vivo applications : Part 2 - In vivo developments and present clinical applications.

Authors:  Jean-Michel Escoffre; Chloé Mauroy; Thomas Portet; Luc Wasungu; Aurelie Paganin-Gioanni; Muriel Golzio; Justin Teissié; Marie-Pierre Rols
Journal:  Biophys Rev       Date:  2009-11-10

Review 8.  What you always needed to know about electroporation based DNA vaccines.

Authors:  Anita Gothelf; Julie Gehl
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

Review 9.  A brief overview of electroporation pulse strength-duration space: a region where additional intracellular effects are expected.

Authors:  James C Weaver; Kyle C Smith; Axel T Esser; Reuben S Son; T R Gowrishankar
Journal:  Bioelectrochemistry       Date:  2012-03-14       Impact factor: 5.373

10.  Electrochemotherapy: aspects of preclinical development and early clinical experience.

Authors:  John O Larkin; Christopher G Collins; Simon Aarons; Mark Tangney; Maria Whelan; Seamus O'Reily; Oscar Breathnach; Declan M Soden; Gerald C O'Sullivan
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.